MentionFox
Home › Executive changes › Adicet Bio, Inc.
Leadership changes · ACET · SEC Form 8-K, Item 5.02

Leadership changes at Adicet Bio, Inc. (2026)

Before you join, sell to or invest in Adicet Bio, Inc.

MentionFox check on Adicet Bio, Inc.: only 1 source on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/executive-changes/adicet-bio

Check Adicet Bio, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Adicet Bio, Inc.?

Who joined and who left Adicet Bio, Inc. (ACET)? 1 departure reported on 2026-11-13, each cited to the company's own filing.

Andrew Sinclair left the role of Director at Adicet Bio, Inc., effective November 13, 2026. As of November 14, 2026, Adicet Bio, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on November 13, 2026, naming 1 departure (Form 8-K, November 13, 2026).

Adicet Bio, Inc. announced the departure of its Director on Nov 13. 29 companies changed executives this week, 1 had other signals.

Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.

ONITY GROUP INC.announced the departure of its Chief Investment Officer
Adicet Bio, Inc.announced the departure of its Director
MAMMOTH ENERGY SERVICES, INC.announced the departure of its Chief Operating Officer
CERENOME, INC.named a new Director
Cohen & Co Inc.named a new Chief Executive Officer
Check one company free All companies that changed executives this week

Woodline Partners LP also filed stake reports on 19 other companies ↓

Sell to companies like Adicet Bio, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Changes1
Out (departing)1
Latest filing2026-11-13

Adicet Bio, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-11-13. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Adicet Bio, Inc. files it.

Also on the record for Adicet Bio, Inc.

DateRecordFigureOur pageSource
October 28, 2026Stake report, Schedule 13G/A, by Franklin Templeton, Inc.7.7% of the class5%+ stakesSource
October 23, 2026Stake report, Schedule 13G, by Zedek Daniel Clayton5.4% of the class5%+ stakesSource
August 14, 2026Stake report, Schedule 13G/A, by RA Capital Management, L.P.9.9% of the class5%+ stakesSource
May 15, 2026Stake report, Schedule 13G/A, by Woodline Partners LP3.3% of the class5%+ stakesSource
April 13, 2026Stake report, Schedule 13G/A, by RA Capital Management, L.P.12.3% of the class5%+ stakesSource
April 10, 2026Stake report, Schedule 13D/A, by ORBIMED ADVISORS LLC8.8% of the class5%+ stakesSource
February 17, 2026Stake report, Schedule 13G, by Woodline Partners LP6.5% of the class5%+ stakesSource
February 17, 2026Stake report, Schedule 13G/A, by RA Capital Management, L.P.9.9% of the class5%+ stakesSource
February 17, 2026Stake report, Schedule 13G/A, by TANG CAPITAL MANAGEMENT, LLC0.1% of the class5%+ stakesSource
January 29, 2026Stake report, Schedule 13G, by Franklin Resources, Inc.6.5% of the class5%+ stakesSource
October 10, 2025Stake report, Schedule 13D/A, by ORBIMED ADVISORS LLC9.6% of the class5%+ stakesSource

Selling to them or working with them? See who runs Adicet Bio, Inc. now and the warning signs.

Free to see. No signup.

Keep reading

More on Adicet Bio, Inc. and the records around it.

Adicet Bio, Inc. elsewhere on the record

Companies that share a holder

Want the whole picture on Adicet Bio, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Adicet Bio, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Adicet Bio, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    12 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledIn / outPersonRoleEffectiveSource
2026-11-13OutDirector2026-11-138-K, 2026-11-13

Why did they leave? What the filings say

For each named departure below, the sentence from the company's own filing that gives a reason, word for word. Where a filing gives none, it says so here; nothing is inferred.

Who leads Adicet Bio, Inc., as last reported?

For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.

Selling to Adicet Bio, Inc.?

New leaders reset buying decisions — get the Full Report on Adicet Bio, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.

Get the Full Report

Watch Adicet Bio, Inc.

Hiring for a seat like this?

Find people with the same kind of experience as the Director at Adicet Bio, Inc., with the record behind each one.

Find candidates like Director at Adicet Bio, Inc.

Every change, in the filing's words

Filed 2026-11-13 · 8-K

Departing: Andrew Sinclair, Director, effective 2026-11-13

On November 11, 2026, Andrew Sinclair, Ph.D., a Class III member of the board of directors (the "Board") of Adicet Bio, Inc. (the "Company"), notified the Company of his resignation from the Board, the Audit Committee of the Board (the "Audit Committee") and the Nominating and Corporate Governance Committee of the Board (the "NCG Committee"), effective on November 13, 2026.

Also stated in this filing

  • Departure of Directors or Certain Officers; Election of Directors.
  • Effective upon Dr. Sinclair's resignation, the size of the Board will be reduced from seven to six.
  • On November 13, 2026, upon the recommendation of the NCG Committee of the Board, the Board appointed current director Michael Grissinger to serve on the Audit Committee.
  • The Board determined that Mr. Grissinger meets the requirements for independence of audit committee members under the listing standards of The Nasdaq Stock Market and the Securities and Exchange Act of 1934, as amended.
  • Mr. Grissinger was also appointed to serve as chairperson of the NCG Committee.

Tools for this story

Each opens in a new tab, filled in for Adicet Bio, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.

Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.

Not for employment, credit or tenancy decisions. MentionFox research is for sales, partnership and investor research. Permitted use

Cite this page

Permanent URL: https://mentionfox.com/executive-changes/adicet-bio
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Adicet Bio, Inc. executive departure 2026. MentionFox, 2026-11-14. https://mentionfox.com/executive-changes/adicet-bio